Teva stock pops on Q2 results, CEO sees 'significant' potential for trio of branded drugs
Teva Pharmaceuticals Reports Strong Q3 2023 Results Raises Revenue Forecast :: Israeli Financial News - The Israeli Economic World
Teva's new CEO Schultz to take post Wednesday | The Times of Israel
Teva and Royalty Pharma Join Forces to Expedite Olanzapine LAI Program | American Pharmaceutical Review - The Review of American Pharmaceutical Business & Technology
Teva Pharmaceutical Statistics, Facts, Revenue, Subsidiaries
 "Teva Pharmaceutical's Q2 profit tops forecast, reaffirms 2020 outlook")
Teva Pharmaceutical's Q2 profit tops forecast, reaffirms 2020 outlook
Richard Daniell on LinkedIn: Teva Reports First Quarter 2022 Financial Results
Teva Pharmaceutical Industries Limited 2021 Q4 - Results - Earnings Call Presentation (NYSE:TEVA) | Seeking Alpha
Teva Announces Results from Exploratory 52-Week Phase 2 PRIDE-HD Study of Pridopidine in Huntington Disease - Huntington's Disease News
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Teva Reports Second Quarter 2023 Financial Results
Teva Reports Fourth Quarter and Full Year 2020 Financial Results | Business Wire
Teva Pharmaceuticals Interviews | Comparably
Infographic: Teva Pharmaceuticals (TEVA) Q1 2020 earnings results | AlphaStreet
Teva Pharmaceutical Industries Ltd. - Investors
Teva, Cephalon Lose Fight Over EU's Antitrust Sleep Drug Fine - Bloomberg
Teva Pharmaceutical Industries Limited 2023 Q3 - Results - Earnings Call Presentation (NYSE:TEVA) | Seeking Alpha
Drugmaker Teva does not see big impact on business from Israel-Hamas war | Reuters
Teva Pharmaceuticals on LinkedIn: #pivottogrowth #quarterlyresults #earnings #teva
Teva, with a $4.25B opioid settlement in hand, eyes return to growth by 2027 | Fierce Pharma
Generic Versions Of Copaxone Take Toll On Teva 3Q Results - Drug Discovery and Development
